Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 5 publications
Discovery of CRBN-recruiting PROTAC degraders of the METTL3-METTL14 complex.
Journal: Medicinal chemistry research : an international journal for rapid communications on design and mechanisms of action of biologically active agents
Published: June 25, 2025
Patent landscape of small molecule inhibitors of METTL3 (2020-present).
Journal: Expert opinion on therapeutic patents
Published: December 25, 2024
Powering up targeted protein degradation through active and passive tumour-targeting strategies: Current and future scopes.
Journal: Pharmacology & therapeutics
Published: June 01, 2024
Overcoming Cancer Drug Resistance Utilizing PROTAC Technology.
Journal: Frontiers in cell and developmental biology
Published: February 09, 2022
Showing 1-5 of 5
Last Updated: 09/26/2026